Polypropylene Versus Polyglactin in Upper Limb Subcuticular Skin Closure
Polypropylene Versus Polyglactin in Upper Limb Subcuticular Skin Closure: Results From a Randomized Controlled Trial.
調査の概要
状態
詳細な説明
Background and Rationale Although previous studies have compared absorbable and non-absorbable sutures, most did not specifically evaluate standardized scar outcomes for subcuticular closure in the upper limb. While upper limb wounds may not carry the same aesthetic priority as facial wounds, scars in this region are highly visible and can adversely affect patients' psychological well-being. Subcuticular suturing is commonly used to improve cosmetic outcomes and reduce wound complications. Both Polypropylene (non-absorbable) and Polyglactin (absorbable) are widely used materials, yet their comparative performance in subcuticular skin closure remains controversial.
Aim and Objectives
Primary objective:
- To compare cosmetic outcomes of subcuticular skin closure using Polypropylene and Polyglactin
Secondary objectives:
- To compare postoperative wound complication rates (including infection, wound dehiscence, and hematoma formation) between polypropylene and polyglactin sutures
- To assess patient-reported discomfort and satisfaction associated with each suture material
- To assess the influence of the nature of surgery (elective vs trauma) on wound healing outcomes for each suture type
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Mohamed Elsaid Hamisa
- 電話番号:+201092248136
- メール:mohamedhamisa442@gmail.com
研究場所
-
-
-
Menoufia Governorate、エジプト、33511
- 募集
- Shebin El Koum teaching Hospital
-
コンタクト:
- Mohamed Elsaid Hamisa
- 電話番号:+201092248136
- メール:mohamedhamisa442@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adults aged ≥18 years
- Patients undergoing any surgical procedure involving the upper limb
- Procedures performed in either elective or emergency settings
- Wounds suitable for primary subcuticular skin closure
- Ability to provide informed consent
Exclusion Criteria:
- Heavily contaminated or infected wounds
- Patients with uncontrolled diabetes mellitus, chronic steroid use, immunosuppression or peripheral vascular disease
- Crush injuries and wounds with significant tissue loss
- Known allergy to suture material
- Delayed primary closure wounds
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cosmetic outcome measured using the Patient and Observer Scar Assessment Scale (POSAS) total score (range 6-60)
時間枠:Baseline
|
Scar quality will be evaluated using the Patient and Observer Scar Assessment Scale (POSAS), which includes both patient-reported and observer-reported components.
Each item is scored from 1 to 10, with total scores ranging from 6 to 60, where lower scores indicate better cosmetic outcome.
|
Baseline
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of surgical site infection (SSI) (number and percentage of patients)
時間枠:Baseline
|
Surgical site infection will be assessed based on clinical criteria including the presence of purulent discharge, localized swelling, erythema, warmth, or wound dehiscence, with or without positive bacterial culture.
The outcome will be reported as the number and percentage of patients who develop SSI during the follow-up period.
|
Baseline
|
|
Incidence of wound dehiscence (number and percentage of patients)
時間枠:Baseline
|
Wound dehiscence will be defined as partial or complete separation of the surgical wound edges after closure.
The outcome will be assessed clinically during follow-up visits and reported as the number and percentage of patients who develop wound dehiscence.
|
Baseline
|
|
Incidence of hematoma formation (number and percentage of patients)
時間枠:Baseline
|
Hematoma formation will be defined as a localized collection of blood at the surgical site, identified clinically by swelling, discoloration, or tension, with or without the need for evacuation.
The outcome will be assessed during follow-up and reported as the number and percentage of patients who develop a hematoma.
|
Baseline
|
|
Patient satisfaction measured using a 5-point Likert scale (score range 1-5)
時間枠:Baseline
|
Patient satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied.
The outcome will be reported as a numerical score reflecting the patient's overall satisfaction with the surgical result.
|
Baseline
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7. doi: 10.1097/01.prs.0000122207.28773.56.
- Hanna AJ, Sonnier JH, Coladonato C, Destine H, Wilson S, Ciccotti MG, Tjoumakaris FP, Freedman KB. Greater Patient Satisfaction With Use of Nonabsorbable Sutures Compared to Absorbable Sutures for Skin Closure Following Knee Arthroscopy: A Randomized Controlled Trial. Arthrosc Sports Med Rehabil. 2023 Nov 10;5(6):100814. doi: 10.1016/j.asmr.2023.100814. eCollection 2023 Dec.
- Ramadan MS, Elhosseiny AS, Sabaa HA, Nassar SA. Evaluation of the effect of subcuticular skin closure with absorbable suture, polyglactin 910 (Vicryl), versus non-absorbable suture, polypropylene (Prolene), on the risk of wound infection and complications after caesarean section. QJM: An International Journal of Medicine. 2025;118(Suppl_1):hcaf224.173. doi:10.1093/qjmed/hcaf224.173
- Hasdemir PS, Guvenal T, Ozcakir HT, Koyuncu FM, Dinc Horasan G, Erkan M, Oruc Koltan S. Comparison of Subcuticular Suture Materials in Cesarean Skin Closure. Surg Res Pract. 2015;2015:141203. doi: 10.1155/2015/141203. Epub 2015 Aug 27.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- Polypropylene vs Polyglactin
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。